4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-19-006603
Director bought 19,390 shares at an average $0.75 ($14,560)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HILZINGER KURT J Director | 2019-01-30 | Purchase | +4,890 | $0.72 | $3,521 | 164,464 | D: show line 1 in the form |
| HILZINGER KURT J Director | 2019-01-31 | Purchase | +6,300 | $0.75 | $4,725 | 170,764 | D: show line 2 in the form |
| HILZINGER KURT J Director | 2019-02-01 | Purchase | +8,200 | $0.77 | $6,314 | 178,964 | D: show line 3 in the form |
| Open-market purchases · 19,390 sh · avg $0.75 · $14,560 | |||||||
Loading xslF345X03/doc4.xml…